Sources: CFIUS is stepping up scrutiny of past Chinese tech investments in US startups, sending inquiries to some companies about years-old deals
Context & Ripple Effects
This is the retroactive phase of a squeeze that began when CFIUS gained expanded powers over vaguely defined "emerging technologies" in 2018 — fears then were that new deals would slow; what changed by late 2020 is that closed deals are being reopened, with inquiries reaching startups about investments made years earlier.
The arc since only sharpens it: sources reported CFIUS formally scrutinizing past Chinese stakes in early 2021 (even ones that closed years ago), Biden ordered sharper scrutiny of deals touching critical tech and personal data in 2022, and by 2024 US VC firms were pressuring startups to cut ties with Chinese backers altogether.
First-order effects
- US startups holding years-old Chinese investment now face open-ended regulatory exposure on deals they assumed were settled, with possible forced restructuring or divestment on the table.
- Chinese investors in US startups see prior positions turn into liabilities rather than assets, chilling any remaining appetite for minority stakes in American tech.
Second-order effects
- US venture firms rationally front-run the regulators — consistent with later reporting that VCs pressured startups to cut ties with Chinese backers — making private-market pressure, not just CFIUS action, the enforcement mechanism.
Third-order effects
- If retroactive review becomes routine, no cross-border tech deal is ever truly final, structurally splitting US startup capital pools along national lines and pushing Chinese capital toward markets where its exit risk isn't political.
The trend: National-security screening of tech investment is expanding from gatekeeping new deals to unwinding old ones, with US-China capital flows increasingly governed by state review rather than market exit.